Subir Nag, MD | Authors

2710 RIFE MEDICAL LN

HOSPITALIST OFFICE

Articles

Brachytherapy for Carcinoma of the Lung

March 01, 2001

An estimated 157,000 patients died of lung cancer in the United States in the year 2000.[1] Although surgery can be curative, only about 20% of patients are amenable to complete surgical resection. Most of the other patients are treated with radiation

Brachytherapy in the Treatment of Breast Cancer

February 01, 2001

Whole-breast external-beam radiation therapy (EBRT) involves a 6-week course of fractionated treatments. In

Use of Brachytherapy to Preserve Function in Children With Soft-Tissue Sarcomas

March 01, 1999

Pediatric soft-tissue sarcomas are managed with a multimodality treatment program that includes surgery, chemotherapy, and external-beam radiotherapy (teletherapy). The use of teletherapy in young children can

Commentary (Nag): High-Dose-Rate Intraoperative Radiation Therapy For Colorectal Cancer

July 01, 1995

In this issue, Harrison et al give the rationale for intraoperative high-dose-rate brachytherapy (IOHDR) and provide an excellent summary of the Memorial Sloan-Kettering Cancer Center (MSKCC) experience with this treatment. Intraoperative high-dose-rate brachytherapy is used in very few centers [1-4], and its worldwide use has been recently summarized [5,6]. Although our experience with IOHDR at Ohio State University parallels that of Harrison et al in some respects, it differs in others. I will highlight these differences to give readers a more balanced view of IOHDR.